Trifluridine and tipiracil clinical trials
Trifluridine and tipiracil is named as an intervention in 2 current clinical trials in our Ireland, UK, USA, France, Spain, Italy, South Korea, Australia and China registers. 1 is recruiting patients now. The most common phase is Phase 1/2. The sponsor with the most trials is Crescent Biopharma, Inc (1). The most-studied condition is Locally Advanced / Metastatic Solid Tumors.
Patient leaflets for Trifluridine and tipiracil
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Trifluridine and tipiracil
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07335497 · Locally Advanced / Metastatic Solid Tumors
|
Phase 1/2 | Recruiting | Crescent Biopharma, Inc | Ireland, UK, USA, France, Spain, Italy, South Korea, Australia |
|
SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer
NCT07535632 · ClinicalTrials.gov ↗ · Colorectal Neoplasms
|
Phase 2 | Not yet open | Shanghai Zhongshan Hospital | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Trifluridine and tipiracil
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Crescent Biopharma, Inc | 1 |
| Shanghai Zhongshan Hospital | 1 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Trifluridine and tipiracil trials
How many clinical trials are testing Trifluridine and tipiracil?
2 current trials in our Ireland, UK, USA, France, Spain, Italy, South Korea, Australia and China registers name Trifluridine and tipiracil as a drug or biological intervention, as of the registry sync on 23 October 2026. Completed and withdrawn studies are not counted.
Are Trifluridine and tipiracil trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in Ireland, 1 with sites in UK, 1 with sites in USA, 1 with sites in France, 1 with sites in Spain, 1 with sites in Italy, 1 with sites in South Korea and 1 with sites in Australia. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Trifluridine and tipiracil clinical trials?
Crescent Biopharma, Inc (1) and Shanghai Zhongshan Hospital (1). The number in brackets is how many trials each organisation leads.
Are there Trifluridine and tipiracil clinical trials in Ireland?
Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Trifluridine and tipiracil works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Trifluridine and tipiracil works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Trifluridine and tipiracil (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 23 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.